Zhejiang Hongtuo Biotechnology Co., Ltd.

Zhejiang Hongtuo Biotechnology Co., Ltd. is located in the Overseas High-level Talent Innovation Park (Haichuang Park, Future Science and Technology City) in Hangzhou, Zhejiang. It is a company mainly engaged in the processing, production and research and development of biotechnology products for the US market. The company's R&D department uses cutting-edge technologies in many fields such as molecular biology, cell biology, biochemistry, pathophysiology, gene knockout, biochips and animal models. In addition to developing its own brand products to replace important series of products of many mainstream companies in the United States, it also conducts research and development of new non-natural biomacromolecule drug leads and diagnostic probe technologies as a substitute and supplement to antibody drugs and diagnostic reagent technologies. The company's production department focuses on the synthesis, processing and production of non-natural/natural nucleic acids and peptides/proteins. The company currently has a modern R&D center of more than 4,000 square meters, a production base and equipped with large instruments such as peptide synthesizers, nucleic acid synthesizers, HPLC, mass spectrometers, phosphor scintillation analyzers and pulsed field electrophoresis. The R&D team is mainly composed of scientific and knowledge-based personnel, led by a number of senior scientists who studied in world-class scientific research institutions such as Harvard University, the University of California, and the University of Toronto in Canada. The company provides employees with first-class R&D conditions, very competitive wages and benefits, and huge room for development.